GGrantIndex
← Search

Shared Resource: Immune Monitoring & Flow Cytometry

$282,462P30FY2022CANIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

PROJECT SUMMARY: IMMUNE MONITORING & FLOW CYTOMETRY SHARED RESOURCE (IM&FCSR) The Immune Monitoring and Flow Cytometry Shared Resource (IM&FCSR) provides investigators with services and research expertise, supporting a wide range of laboratory and clinical studies in cancer immunology and immunotherapy, transplant biology, infectious disease, and vaccine development. The IM&FCSR produces custom-made tetramer complexes of specific peptide and major histocompatibility complex molecules as unique reagents for assessing antigen-specific T cells and isolating these T cells for therapy trials. Our flow cytometry service offers a wide range of instrumentation, from single-laser benchtop analyzers to complex multi-laser cell sorters. We provide protocol-specific, flow cytometric immune monitoring to support immunotherapy trials. We quantify cytokine proteins, as a measure of immune and other cellular function, at technology platforms of high multiplicity, single cell, and/or ultrasensitivity. We perform specific cellular and molecular assays of native and genetically engineered T cells for laboratory research studies and for monitoring clinical samples. Technical assistance is available for data evaluation and interpretation, as is assistance in optimal experimental design. The different dataset we can provide enable the characterization of immune cell’s phenotypes and functionality, determining immune responses and tracking, and monitoring of immune cell products during immunotherapies.

View original record on NIH RePORTER →